HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-APR-20 6WE4 TITLE HUMAN PARP14 (ARTD8), CATALYTIC FRAGMENT IN COMPLEX WITH COMPOUND 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP14; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 8,ARTD8,B COMPND 5 AGGRESSIVE LYMPHOMA PROTEIN 2,POLY [ADP-RIBOSE] POLYMERASE 14,PARP- COMPND 6 14; COMPND 7 EC: 2.4.2.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP14, BAL2, KIAA1268; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PARP14, ARTD8, MONOPARP, ADP RIBOSYLATION, INHIBITOR COMPLEX, KEYWDS 2 TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.S.SWINGER,L.B.SCHENKEL,K.W.KUNTZ REVDAT 3 18-OCT-23 6WE4 1 REMARK REVDAT 2 01-SEP-21 6WE4 1 JRNL REVDAT 1 24-MAR-21 6WE4 0 JRNL AUTH L.B.SCHENKEL,J.R.MOLINA,K.K.SWINGER,R.ABO,D.J.BLACKWELL, JRNL AUTH 2 A.Z.LU,A.E.CHEUNG,W.D.CHURCH,K.KUNII,K.G.KUPLAST-BARR, JRNL AUTH 3 C.R.MAJER,E.MINISSALE,J.R.MO,M.NIEPEL,C.REIK,Y.REN, JRNL AUTH 4 M.M.VASBINDER,T.J.WIGLE,V.M.RICHON,H.KEILHACK,K.W.KUNTZ JRNL TITL A POTENT AND SELECTIVE PARP14 INHIBITOR DECREASES PROTUMOR JRNL TITL 2 MACROPHAGE GENE EXPRESSION AND ELICITS INFLAMMATORY JRNL TITL 3 RESPONSES IN TUMOR EXPLANTS. JRNL REF CELL CHEM BIOL V. 28 1158 2021 JRNL REFN ESSN 2451-9456 JRNL PMID 33705687 JRNL DOI 10.1016/J.CHEMBIOL.2021.02.010 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 72.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 49116 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2554 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3538 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.4590 REMARK 3 BIN FREE R VALUE SET COUNT : 191 REMARK 3 BIN FREE R VALUE : 0.4760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2986 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 198 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.56000 REMARK 3 B22 (A**2) : -0.52000 REMARK 3 B33 (A**2) : -4.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.113 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.117 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.140 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.755 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3199 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2748 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4335 ; 1.416 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6393 ; 0.938 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 372 ; 6.610 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 167 ;32.044 ;24.192 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 475 ;12.440 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;18.142 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 440 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3606 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 681 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6WE4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248060. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0782 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.31 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52466 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 72.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 13.10 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 13.30 REMARK 200 R MERGE FOR SHELL (I) : 1.02600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 3SMJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LITHIUM NITRATE, 14% W/V PEG REMARK 280 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.05350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.41600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.55450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.41600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.05350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.55450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1608 REMARK 465 ASN A 1609 REMARK 465 ALA A 1610 REMARK 465 ASP A 1611 REMARK 465 MET A 1612 REMARK 465 LYS A 1613 REMARK 465 GLN A 1614 REMARK 465 GLN A 1615 REMARK 465 SER B 1608 REMARK 465 ASN B 1609 REMARK 465 ALA B 1610 REMARK 465 ASP B 1611 REMARK 465 MET B 1612 REMARK 465 LYS B 1613 REMARK 465 TYR B 1701 REMARK 465 ALA B 1702 REMARK 465 GLY B 1703 REMARK 465 LYS B 1704 REMARK 465 ASN B 1705 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 EDO A 1902 O HOH A 2001 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B1742 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG B1742 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1697 74.56 -102.44 REMARK 500 TYR A1727 -65.68 -95.91 REMARK 500 TYR B1727 -66.50 -101.47 REMARK 500 TYR B1727 -66.50 -102.79 REMARK 500 ASN B1765 60.55 -154.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FDR A 1901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1906 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1907 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TYG B 1901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 1902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 1903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1906 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 1907 DBREF 6WE4 A 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 DBREF 6WE4 B 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 SEQADV 6WE4 SER A 1608 UNP Q460N5 EXPRESSION TAG SEQADV 6WE4 ASN A 1609 UNP Q460N5 EXPRESSION TAG SEQADV 6WE4 ALA A 1610 UNP Q460N5 EXPRESSION TAG SEQADV 6WE4 SER B 1608 UNP Q460N5 EXPRESSION TAG SEQADV 6WE4 ASN B 1609 UNP Q460N5 EXPRESSION TAG SEQADV 6WE4 ALA B 1610 UNP Q460N5 EXPRESSION TAG SEQRES 1 A 194 SER ASN ALA ASP MET LYS GLN GLN ASN PHE CYS VAL VAL SEQRES 2 A 194 GLU LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SEQRES 3 A 194 SER LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU SEQRES 4 A 194 LYS ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER SEQRES 5 A 194 TYR GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY SEQRES 6 A 194 GLN THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP SEQRES 7 A 194 ALA GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN SEQRES 8 A 194 ARG SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS SEQRES 9 A 194 GLY THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN SEQRES 10 A 194 ASP THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS SEQRES 11 A 194 VAL TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS SEQRES 12 A 194 GLY ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO SEQRES 13 A 194 GLN ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN SEQRES 14 A 194 VAL HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR SEQRES 15 A 194 GLN ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 194 SER ASN ALA ASP MET LYS GLN GLN ASN PHE CYS VAL VAL SEQRES 2 B 194 GLU LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SEQRES 3 B 194 SER LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU SEQRES 4 B 194 LYS ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER SEQRES 5 B 194 TYR GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY SEQRES 6 B 194 GLN THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP SEQRES 7 B 194 ALA GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN SEQRES 8 B 194 ARG SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS SEQRES 9 B 194 GLY THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN SEQRES 10 B 194 ASP THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS SEQRES 11 B 194 VAL TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS SEQRES 12 B 194 GLY ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO SEQRES 13 B 194 GLN ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN SEQRES 14 B 194 VAL HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR SEQRES 15 B 194 GLN ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS HET FDR A1901 14 HET EDO A1902 4 HET EDO A1903 4 HET EDO A1904 4 HET EDO A1905 4 HET EDO A1906 4 HET EDO A1907 4 HET TYG B1901 40 HET GOL B1902 6 HET GOL B1903 6 HET EDO B1904 4 HET EDO B1905 4 HET EDO B1906 4 HET EDO B1907 4 HETNAM FDR 2-METHYL-3,5,6,7-TETRAHYDRO-4H-CYCLOPENTA[4,5]THIENO[2, HETNAM 2 FDR 3-D]PYRIMIDIN-4-ONE HETNAM EDO 1,2-ETHANEDIOL HETNAM TYG 8-METHYL-2-{[(PYRIDIN-4-YL)SULFANYL]METHYL}QUINAZOLIN- HETNAM 2 TYG 4(3H)-ONE HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 FDR C10 H10 N2 O S FORMUL 4 EDO 10(C2 H6 O2) FORMUL 10 TYG C15 H13 N3 O S FORMUL 11 GOL 2(C3 H8 O3) FORMUL 17 HOH *198(H2 O) HELIX 1 AA1 ASP A 1626 SER A 1641 1 16 HELIX 2 AA2 ASN A 1653 ASN A 1671 1 19 HELIX 3 AA3 ASP A 1685 GLY A 1687 5 3 HELIX 4 AA4 SER A 1688 GLY A 1696 1 9 HELIX 5 AA5 ASN A 1718 ALA A 1723 1 6 HELIX 6 AA6 GLU B 1628 SER B 1641 1 14 HELIX 7 AA7 ASN B 1653 ASN B 1671 1 19 HELIX 8 AA8 ASP B 1685 GLY B 1687 5 3 HELIX 9 AA9 SER B 1688 GLY B 1696 1 9 HELIX 10 AB1 ASN B 1718 ALA B 1723 1 6 SHEET 1 AA110 GLU A1677 THR A1684 0 SHEET 2 AA110 LYS A1736 LEU A1744 -1 O VAL A1741 N LEU A1680 SHEET 3 AA110 ALA A1791 ARG A1800 -1 O PHE A1799 N LYS A1736 SHEET 4 AA110 ARG A1644 GLN A1652 -1 N ARG A1644 O ARG A1800 SHEET 5 AA110 PHE A1617 LEU A1622 -1 N LEU A1622 O ILE A1648 SHEET 6 AA110 PHE B1617 GLU B1621 -1 O PHE B1617 N VAL A1619 SHEET 7 AA110 ARG B1644 GLN B1652 -1 O ARG B1650 N VAL B1620 SHEET 8 AA110 ALA B1791 ARG B1800 -1 O THR B1798 N LYS B1647 SHEET 9 AA110 LYS B1736 LEU B1744 -1 N LYS B1736 O PHE B1799 SHEET 10 AA110 GLU B1677 THR B1684 -1 N LEU B1680 O VAL B1741 SHEET 1 AA2 4 THR A1713 ALA A1716 0 SHEET 2 AA2 4 LEU A1782 ALA A1785 -1 O ALA A1785 N THR A1713 SHEET 3 AA2 4 THR A1772 THR A1774 -1 N VAL A1773 O VAL A1784 SHEET 4 AA2 4 TYR A1748 HIS A1750 1 N THR A1749 O THR A1774 SHEET 1 AA3 4 THR B1713 ALA B1716 0 SHEET 2 AA3 4 LEU B1782 ALA B1785 -1 O ALA B1785 N THR B1713 SHEET 3 AA3 4 THR B1772 THR B1774 -1 N VAL B1773 O VAL B1784 SHEET 4 AA3 4 TYR B1748 HIS B1750 1 N THR B1749 O THR B1774 SSBOND 1 CYS A 1618 CYS B 1618 1555 1555 2.08 SITE 1 AC1 5 HIS A1682 GLY A1683 TYR A1714 SER A1722 SITE 2 AC1 5 TYR A1727 SITE 1 AC2 8 PHE A1617 ASN A1693 ARG A1694 HOH A2001 SITE 2 AC2 8 PHE B1617 VAL B1689 ASN B1693 EDO B1905 SITE 1 AC3 6 PRO A1690 HIS A1691 HOH A2004 ASP B1731 SITE 2 AC3 6 ARG B1735 HIS B1737 SITE 1 AC4 3 HIS A1737 THR A1798 GLY B1687 SITE 1 AC5 2 ILE A1651 TYR A1792 SITE 1 AC6 3 CYS A1618 GLN A1652 HOH A2017 SITE 1 AC7 5 LEU A1755 VAL A1757 PRO A1758 PRO A1759 SITE 2 AC7 5 HOH A2003 SITE 1 AC8 14 HIS B1682 GLY B1683 THR B1684 ASP B1685 SITE 2 AC8 14 TYR B1714 TYR B1721 SER B1722 THR B1726 SITE 3 AC8 14 TYR B1727 ARG B1729 PRO B1763 GLN B1764 SITE 4 AC8 14 PRO B1766 HOH B2010 SITE 1 AC9 5 HIS B1682 THR B1684 HOH B2001 HOH B2021 SITE 2 AC9 5 HOH B2041 SITE 1 AD1 11 PHE B1697 ASN B1698 ARG B1699 GLY B1710 SITE 2 AD1 11 LYS B1711 THR B1713 ALA B1785 PHE B1786 SITE 3 AD1 11 TYR B1787 ASP B1788 HOH B2034 SITE 1 AD2 3 GLN B1652 ASN B1653 TYR B1792 SITE 1 AD3 7 LYS A1647 GLU A1649 EDO A1902 HOH A2001 SITE 2 AD3 7 PHE B1617 PRO B1690 ARG B1694 SITE 1 AD4 7 LYS B1663 MET B1667 LYS B1670 HIS B1753 SITE 2 AD4 7 SER B1754 HOH B2004 HOH B2014 SITE 1 AD5 4 ALA B1662 THR B1666 HOH B2004 HOH B2012 CRYST1 40.107 67.109 144.832 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024933 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014901 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006905 0.00000